Rani Therapeutics
RANI
RANI
24 hedge funds and large institutions have $34.5M invested in Rani Therapeutics in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
14% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 7
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
24
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$9.64M | |
| 2 | +$6.5M | |
| 3 | +$848K | |
| 4 |
BlackRock
New York
|
+$582K |
| 5 |
Millennium Management
New York
|
+$439K |
Top Sellers
| 1 | -$818K | |
| 2 | -$228K | |
| 3 | -$82K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$27.4K |
| 5 |
JPMorgan Chase & Co
New York
|
-$24.7K |